Merck (MRK) Total Current Liabilities (2016 - 2025)
Merck (MRK) has disclosed Total Current Liabilities for 17 consecutive years, with $28.3 billion as the latest value for Q4 2025.
- Quarterly Total Current Liabilities changed 0.33% to $28.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.3 billion through Dec 2025, changed 0.33% year-over-year, with the annual reading at $28.3 billion for FY2025, 0.33% changed from the prior year.
- Total Current Liabilities for Q4 2025 was $28.3 billion at Merck, down from $28.6 billion in the prior quarter.
- The five-year high for Total Current Liabilities was $29.6 billion in Q3 2024, with the low at $21.9 billion in Q2 2021.
- Average Total Current Liabilities over 5 years is $25.1 billion, with a median of $24.7 billion recorded in 2022.
- The sharpest move saw Total Current Liabilities dropped 15.34% in 2022, then increased 28.11% in 2024.
- Over 5 years, Total Current Liabilities stood at $23.9 billion in 2021, then grew by 1.54% to $24.2 billion in 2022, then grew by 6.0% to $25.7 billion in 2023, then increased by 10.61% to $28.4 billion in 2024, then dropped by 0.33% to $28.3 billion in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods came in at $28.3 billion, $28.6 billion, and $26.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.